Dr. Hager El-Geed’s research focuses on advancing clinical pharmacy practice through evidence-based interventions that optimize medication therapy and improve patient outcomes in nephrology. Her primary interests include renal dose adjustment, medication safety in advanced chronic kidney disease (CKD) and dialysis, and the integration of digital health solutions to enhance clinical decision-making. She is particularly interested in the pharmacotherapeutic management of CKD-related complications such as anemia, mineral bone disorders, and electrolyte imbalances. Through her research, Dr. El-Geed aims to bridge gaps between clinical evidence and real-world practice in renal pharmacotherapy and medication management.